Related Experiment Video
Updated: Apr 11, 2026

Intravital Microscopy of Tumor-associated Vasculature Using Advanced Dorsal Skinfold Window Chambers on Transgenic Fluorescent Mice
Published on: January 19, 2018
Recent Advances and Strategies in Tumor Vasculature Targeted Nano-Drug Delivery Systems
Man Ying, Guanyu Chen, Weiyue Lu1
1Department of Pharmaceutics, School of Pharmacy, Fudan University, Zhanghen Road 826 201203, Shanghai, China. wylu@shum.edu.cn.
Abstract:
In recent decades, targeted nano-drug delivery systems have attracted extensive attention in cancer therapy for their efficient drug delivery and tumor site specificity. Tumor vasculature, including angiogenesis and vasculogenic mimicry is associated tightly with tumor growth, progression and metastasis. Therefore, nano-drug delivery systems targeting tumor vasculature are becoming a promising approach for tumor treatment. As complicated mechanisms and various factors are involved in the tumor vasculature, different ligands modified on the surface of nanocarriers acquire active targeting through binding to the receptors over-expressed by cancer cells or angiogenic endothelial cells. In this review, the tumor vasculature characteristics are briefly described and the recent advances and potential strategies in tumor vasculature targeted nano-drug delivery systems are introduced.
Insights
Targeted nano-drug delivery systems offer efficient cancer therapy by targeting tumor vasculature. Ligand-modified nanocarriers enhance drug delivery specificity to tumors, improving treatment outcomes.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Targeted nano-drug delivery systems are crucial in cancer therapy.
- Tumor vasculature, including angiogenesis and vasculogenic mimicry, drives tumor growth and metastasis.
- Targeting tumor vasculature presents a promising strategy for cancer treatment.
Purpose of the Study:
- To review tumor vasculature characteristics.
- To introduce recent advances in nano-drug delivery systems targeting tumor vasculature.
- To discuss potential strategies for enhanced tumor treatment.
Main Methods:
- Review of scientific literature on nano-drug delivery and tumor vasculature.
- Analysis of ligand modification on nanocarriers for active targeting.
- Description of receptor-ligand interactions for tumor cell and endothelial cell targeting.
Main Results:
- Nano-drug delivery systems demonstrate efficient drug delivery and tumor site specificity.
- Ligands on nanocarriers enable active targeting by binding to over-expressed receptors.
- Targeting tumor vasculature is a viable approach for cancer therapy.
Conclusions:
- Nano-drug delivery systems targeting tumor vasculature are a promising cancer treatment strategy.
- Ligand-modified nanocarriers improve targeting efficiency and specificity.
- Further research into tumor vasculature targeting holds potential for improved cancer therapies.
Related Concept Videos
Modified-Release Drug Delivery Systems: Site-Targeted
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Mechanism of Angiogenesis

